NDC 13985-009-30 - EnteDerm
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-009
- Requested NDC
- 13985-009-30
- Package NDCs from labels
- 13985-009-75, 13985-009-15, 13985-009-30, 13985-009-40
- Manufacturer
- MWI | Med-Pharmex, Inc.
- Effective date
- 1998-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nystatin, Neomycin Sulfate, Thiostrepton and Triamcinolone Acetonide Ointment | MWI | Med-Pharmex, Inc. | 1998-10-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Sandoz Inc. | 99d9030f-9118-412c-a377-d1df1c8fa723 | 2021-08-31 | Warnings, Adverse reactions | 057Y626693 |
| Nystatin | NYSTATIN | Macleods Pharmaceuticals Limited | d8ebb61a-a326-4f0d-a346-c3db045c3fb0 | 2021-08-25 | Adverse reactions | BDF1O1C72E |
| nystatin | NYSTATIN | Proficient Rx LP | 04d795f3-aad7-4b79-8ebc-43c500afe39b | 2021-08-01 | Adverse reactions | BDF1O1C72E |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Strides Pharma Science Limited | cfd1f3bd-0284-443b-8bdf-3e44f1f9bc82 | 2021-06-23 | Adverse reactions | F446C597KA |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Glenmark Pharmaceuticals Inc., USA | 44a37f35-e533-4b09-bbcf-97ffaff1920b | 2021-01-31 | Adverse reactions | BDF1O1C72E F446C597KA |
| Nystatin | NYSTATIN | Macleods Pharmaceuticals Limited | fe3db8b2-9de4-4f9e-b763-8536a1e4cea8 | 2021-01-29 | Adverse reactions | BDF1O1C72E |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN, POLYMYXIN B SULFATES, DEXAMETHASONE | Proficient Rx LP | bd9f3220-6d42-4863-aa2a-b17b138d095d | 2021-01-01 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | Proficient Rx LP | d55f1783-9c49-4f90-9ff8-6f132e7b325e | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | Proficient Rx LP | aa7b8a3f-06dd-4190-96a5-f86195bd2197 | 2021-01-01 | Warnings, Adverse reactions | 057Y626693 |
| TRIAMCINOLONE ACETONIDE | TRIAMCINOLONE ACETONIDE | Cintex Services, LLC | be0270a4-5596-499e-aea2-8e63b3edc852 | 2020-11-20 | Adverse reactions | F446C597KA |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | Asclemed USA, Inc. | 7c78ec84-8b7c-42f1-a879-3bf27a1daa71 | 2020-10-30 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| Nystatin and Triamcinolone Acetonide | NYSTATIN AND TRIAMCINOLONE ACETONIDE | Glenmark Pharmaceuticals Inc., USA | aee696ad-9b16-42db-a6ac-49932efb9fa5 | 2020-09-21 | Adverse reactions | BDF1O1C72E F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Proficient Rx LP | e5e3a38d-717d-4412-80d3-7130100add0a | 2020-09-01 | Adverse reactions | F446C597KA |
| KENALOG-40 | TRIAMCINOLONE ACETONIDE | Asclemed USA, Inc. | 0bc9c75f-963c-40b0-995b-dfcbd50371a5 | 2020-05-06 | Warnings, Adverse reactions | F446C597KA |
| Nystatin | NYSTATIN OINTMENT | Proficient Rx LP | 711950c4-1889-4acd-ab76-9a16176ce1e4 | 2020-03-01 | Adverse reactions | BDF1O1C72E |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Proficient Rx LP | 41c1fe93-0509-4cf6-ac35-049028b731de | 2019-12-01 | Adverse reactions | F446C597KA |
| Nystatin | NYSTATIN | Proficient Rx LP | 5ef15e1c-66dc-4858-8552-d83e42c3883e | 2019-11-01 | Adverse reactions | BDF1O1C72E |
| NYSTATIN | NYSTATIN | Leading Pharma, LLC | 8900ba02-2c6a-4dd4-b82f-45620c06e255 | 2019-09-19 | Adverse reactions | BDF1O1C72E |
| Nystatin Topical Powder | NYSTATIN TOPICAL POWDER | Epic Pharma, LLC | 7f313a3b-7a4c-47fb-ad9f-e267514db527 | 2018-05-02 | Adverse reactions | BDF1O1C72E |
| Water-Jel 3-in-1 Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE | Water-Jel Technologies | d5fcaffd-af38-4285-a79c-6df7424c76fa | 2017-11-16 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.